Caribou Biosciences (CRBU) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist

2.120
+0.090+4.43%

Close Sep 13 16:00 ET

2.140
+0.020+0.94%

Post 19:33 ET

191.57MMarket Cap-1606P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Vir Biotechnology Names Jason O'Byrne Finance Chief
MT NewswiresSep 10 08:55 ET
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
Moomoo NewsSep 4 07:31 ET · Ratings
Caribou Biosciences Announces CFO Resignation and Succession Plan
TipRanksSep 3 16:30 ET
Express News | Caribou Biosciences- Plans to Appoint Ryan Fischesser to Assume Role of Principal Accounting Officer, Effective as Close of Business on Sept 27
ReutersSep 3 16:03 ET
Express News | Caribou Biosciences Inc - on Sept 1 Jason O'byrne, CFO, Informed of Intent to Resign From Position
ReutersSep 3 16:02 ET
Express News | Caribou Biosciences Inc: CB-010 Gallop Phase 1 Trial in Patients With Ln and Erl Is on Track to Initiate by Ye 2024
ReutersSep 3 08:04 ET

Comments

FattyChick

18 hours ago

Next 3 stocks keeping an eye on.

$Caribou Biosciences (CRBU.US)$
$Gossamer Bio (GOSS.US)$
$Archer Aviation (ACHR.US)$
Gonna add a position for each again.

Trytosaveabit

Sep 3 07:01

News

$Caribou Biosciences (CRBU.US)$ Reuters· just
Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory Sle and to CB-012 in Relapsed or Refractory Aml

Jaguar8

Jun 2 20:24

NEWS

$Caribou Biosciences (CRBU.US)$
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Caribou Biosciences presented promising clinical data from its CB-010 ANTLER Phase 1 trial at the 2024 ASCO Annual Meeting. CB-010, an allogeneic CAR-T cell therapy with partial HLA matching, showed potential to rival currently approved autologous CAR-T therapies in safety an...

Trytosaveabit

Apr 16 05:31

Hmm?

$Caribou Biosciences (CRBU.US)$ Got a inverted hammer on the daily! Its wick actually broke above the downtrend continuation wedge! Its Really OS RSI 7 = 14.58! RSI 14 = 24.96! MACD Looks as if its fixing to GC? So lets just see how this turns out? Just thinking outloud

Trytosaveabit

Apr 4 15:07

Update

$Caribou Biosciences (CRBU.US)$ Caribou Biosciences Expands Clinical Development Of CB-010 With FDA Clearance Of IND In Lupus
Benzinga· 4 mins ago
- FDA has cleared Caribou's IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 --
-- Driven by encouraging initial safety and efficacy in the ongoing ANTLER trial for r/r B-NHL, CB-010 clinical development has expanded to include autoimmune diseases --
-- Advancing ANT...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Gene Editing

Intraday+1.53%

CRBU Caribou Biosciences

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target